Page last updated: 2024-08-17

lactose and Bone Cancer

lactose has been researched along with Bone Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, H; Eriksen, EF; Jensen, ON; Moiseeva, EP1
Clar, H; Clar, V; Gruber, G; Hofmann, G; Krippl, P; Langsenlehner, T; Langsenlehner, U; Leithner, A; Renner, W; Windhager, R; Yazdani-Biuki, B1

Other Studies

2 other study(ies) available for lactose and Bone Cancer

ArticleYear
A proteome study of secreted prostatic factors affecting osteoblastic activity: galectin-1 is involved in differentiation of human bone marrow stromal cells.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2003, Volume: 18, Issue:2

    Topics: Bone Marrow Cells; Bone Neoplasms; Cell Adhesion; Cell Differentiation; Cell Division; Collagen; Collagen Type I; Electrophoresis, Gel, Two-Dimensional; Electrophoresis, Polyacrylamide Gel; Fibronectins; Galectin 1; Humans; Lactose; Laminin; Male; Neoplasm Metastasis; Osteoblasts; Peptide Mapping; Prostatic Neoplasms; Proteome; Recombinant Proteins; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured

2003
The LCT 13910 C/T polymorphism as a risk factor for osteoporosis, has no impact on metastatic bone disease in breast cancer.
    Breast cancer research and treatment, 2008, Volume: 112, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Disease-Free Survival; Female; Genotype; Humans; Lactose; Middle Aged; Neoplasm Metastasis; Osteoporosis; Polymorphism, Genetic; Risk Factors

2008